What Happened
Cadott Miller Pharmacy in Cadott, Wisconsin agreed to pay $20,000 to settle civil allegations that it repeatedly dispensed controlled substances outside the usual course of professional pharmacy practice.
Between 2017 and 2019, DEA executed several administrative inspection warrants at the pharmacy. Investigators alleged the pharmacy filled combinations of controlled substances with no legitimate medical purpose that were specifically combined to create or enhance abusive and euphoric effects, dispensed drugs with no valid prescription on file, allowed unauthorized early refills, and dispensed Schedule II drugs for opioid dependence treatment, which is prohibited under federal law.
After determining the pharmacy's compliance measures were unsuccessful, DEA served an immediate suspension order on its registration in December 2019, and the pharmacy voluntarily surrendered its DEA registration in January 2020. The $20,000 civil settlement, reflecting the pharmacy's limited ability to pay a larger penalty, was announced April 29, 2022.
What Went Wrong
- Known dangerous drug combinations were filled repeatedly. Combinations chosen specifically for abuse potential should have been flagged and refused at the point of dispensing.
- Prescription validation broke down entirely. Dispensing with no valid prescription on file and allowing unauthorized early refills points to an absence of even basic pharmacy verification steps.
- Multiple inspection cycles didn't fix the problem. DEA inspected the pharmacy repeatedly between 2017 and 2019 before ultimately suspending its registration — the violations persisted across that period rather than being corrected after the first inspection.
How It Could Have Been Prevented
- Implement a hard stop in the pharmacy dispensing system for known high-abuse-potential drug combinations pending pharmacist review.
- Require a valid, verifiable prescription on file before any controlled substance is dispensed, with no exceptions for early refills absent documented justification.
- Treat a DEA administrative inspection finding as a mandatory trigger for an independent compliance overhaul, not a one-time fix.
- Establish escalating consequences (up to registration surrender) for repeat violations identified across multiple inspection cycles.
Related Guidance
- 15 Red Flags of Drug Diversion — Prescription-pattern and drug-combination red flags.
- Regulatory Guide — DEA inspection process and registration suspension criteria.
- Community Pharmacy Self-Assessment Checklist — Self-assessment for retail and specialty pharmacies.
- Policy Templates — Prescription validation and early-refill policy templates.